Anti-porin antibodies prevent excitotoxic and ischemic damage to brain tissue

Jose L Perez Velazquez1, Larisa Kokarovtseva, Michael Weisspapir

  • 1The Hospital for Sick Children, Brain and Behaviour Programme, Department of Paediatrics, University of Toronto, Toronto, Canada. jlpv@sickkids.ca

Journal of Neurotrauma
|August 12, 2003
PubMed

Insights

Anti-porin antibodies prevent cell death caused by excitotoxicity and ischemia. These antibody fragments target porin, a mitochondrial protein, offering a potential new therapeutic strategy for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Immunology

Background:

  • Mitochondrial permeability transition (MPT) is a key event in cell death pathways following excitotoxic/oxidative stress.
  • Porin, an outer mitochondrial membrane protein, is implicated in MPT and apoptosis.

Purpose of the Study:

  • To test if anti-porin antibodies can prevent cell death induced by excitotoxicity and ischemia.
  • To investigate the role of porin in neuronal death.

Main Methods:

  • Generation of anti-porin antibodies.
  • Testing F(ab)(2) antibody fragments for cell penetration and reduction of calcium-induced mitochondrial swelling.
  • Evaluating the effect of antibody fragments on neuronal death in dissociated and organotypic brain slice cultures subjected to excitotoxic and ischemic conditions.

Main Results:

  • Anti-porin antibody fragments successfully penetrated living cells.
  • These fragments reduced calcium-induced mitochondrial swelling, similar to other MPT blockers.
  • Significant decrease in neuronal death was observed in brain cultures exposed to excitotoxic and ischemic insults.

Conclusions:

  • Anti-porin antibody fragments effectively prevent cell damage in brain tissue.
  • Porin plays a critical role in mitochondrial dysfunction and subsequent cell death.
  • Antibodies represent a potential therapeutic approach for treating conditions involving excitotoxicity and ischemia.

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...